Allarity Therapeutics Inc
NASDAQ:ALLR
Earnings Announcements
Allarity Therapeutics Reports First Quarter 2022 Financial Results
Published: 05/27/2022 21:50 GMT
Allarity Therapeutics Inc (ALLR) - Allarity Therapeutics Reports First Quarter 2022 Financial Results.
Allarity Therapeutics Inc - Qtrly Loss per Share $0.56.
Allarity Therapeutics Inc - Qtrly Loss per Share $0.56.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.42
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.42
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45
More details on our Analysts Page.